Protagonist Therapeutics, Inc. · NASDAQ:PTGX

BlackRock, Inc. reported a 14.80% stake in Protagonist Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 29, 2025

BlackRock, Inc. reported a 14.80% stake in Protagonist Therapeutics, Inc., 9,084,682 shares, as a passive investor on Mar 31, 2025. Filed Apr 29, 2025 (Schedule 13G/A).

Stake
14.80%
Shares
9,084,682
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.14.80%9,084,682

Source

View original at SEC

Related